Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2042

1.

Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?

Höcker B, Tönshoff B.

Paediatr Drugs. 2011 Feb 1;13(1):49-69. doi: 10.2165/11538530-000000000-00000. Review.

PMID:
21162600
[PubMed - indexed for MEDLINE]
2.

Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.

Höcker B, Tönshoff B.

Paediatr Drugs. 2009;11(6):381-96. doi: 10.2165/11316100-000000000-00000. Review.

PMID:
19877724
[PubMed - indexed for MEDLINE]
3.

Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.

Tönshoff B, Höcker B.

Pediatr Transplant. 2006 Sep;10(6):721-9. Review.

PMID:
16911497
[PubMed - indexed for MEDLINE]
4.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
5.

Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.

Tsai MK, Wu FL, Lai IR, Lee CY, Hu RH, Lee PH.

Int J Artif Organs. 2009 Jun;32(6):371-80.

PMID:
19670189
[PubMed - indexed for MEDLINE]
6.

Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.

Flechner SM, Kobashigawa J, Klintmalm G.

Clin Transplant. 2008 Jan-Feb;22(1):1-15. doi: 10.1111/j.1399-0012.2007.00739.x. Review.

PMID:
18217899
[PubMed - indexed for MEDLINE]
7.

A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.

Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R.

Clin Transplant. 2000 Dec;14(6):550-4.

PMID:
11127307
[PubMed - indexed for MEDLINE]
8.

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F; ZEUS Study Investigators.

Lancet. 2011 Mar 5;377(9768):837-47. doi: 10.1016/S0140-6736(10)62318-5. Epub 2011 Feb 19. Erratum in: Lancet. 2012 Dec 8;380(9858):1994. Lancet. 2011 Jun 11;377(9782):2006. Wüthrich, Rudolf P [added].

PMID:
21334736
[PubMed - indexed for MEDLINE]
9.

Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.

Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.

Clin Transplant. 2007 Jan-Feb;21(1):101-9.

PMID:
17302598
[PubMed - indexed for MEDLINE]
10.

Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Tredger JM, Brown NW, Dhawan A.

Drugs. 2008;68(10):1385-414. Review.

PMID:
18578558
[PubMed - indexed for MEDLINE]
11.

Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients.

Pescovitz MD, Govani M.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 2):S16-21. Review.

PMID:
11583940
[PubMed - indexed for MEDLINE]
12.

Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A.

Transplantation. 2006 Jul 15;82(1):62-8.

PMID:
16861943
[PubMed - indexed for MEDLINE]
13.

Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.

Penninga L, Wettergren A, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD008852. doi: 10.1002/14651858.CD008852.pub2. Review.

PMID:
22419339
[PubMed - indexed for MEDLINE]
14.

Calcineurin-inhibitor-sparing immunosuppressive protocols.

Bestard O, Cruzado JM, Grinyó JM.

Transplant Proc. 2005 Nov;37(9):3729-32. Review.

PMID:
16386520
[PubMed - indexed for MEDLINE]
15.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
[PubMed - indexed for MEDLINE]
16.

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function.

Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH.

Clin Transplant. 2003;17 Suppl 9:31-4.

PMID:
12795665
[PubMed - indexed for MEDLINE]
17.

Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.

Helal I, Chan L.

Transplant Proc. 2011 Mar;43(2):472-7. doi: 10.1016/j.transproceed.2011.01.054. Review.

PMID:
21440737
[PubMed - indexed for MEDLINE]
18.

SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity.

Höcker B, Feneberg R, Köpf S, Weber LT, Waldherr R, Wühl E, Tönshoff B.

Pediatr Transplant. 2006 Aug;10(5):593-601.

PMID:
16856996
[PubMed - indexed for MEDLINE]
19.

Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.

Chhabra D, Alvarado A, Dalal P, Leventhal J, Wang C, Sustento-Reodica N, Najafian N, Skaro A, Levitsky J, Mas V, Gallon L.

Am J Transplant. 2013 Nov;13(11):2902-11. doi: 10.1111/ajt.12437. Epub 2013 Sep 5.

PMID:
24007570
[PubMed - indexed for MEDLINE]
20.

Calcineurin inhibitor-free protocols: risks and benefits.

Barbari AG, Stephan AG, Masri MA.

Saudi J Kidney Dis Transpl. 2007 Mar;18(1):1-23. Review.

PMID:
17237886
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk